Dusty Linn, PharmD, MBA
@dustylinn.bsky.social
Pharmacist | Critical Care | BCPS | BCCCP
Neuromuscular Monitoring | Sugammadex | Medical Technology
Neuromuscular Monitoring | Sugammadex | Medical Technology
Things we know that continue to be proven:
Neuromuscular monitoring reduces the incidence of residual neuromuscular blockade after surgery. Sugammadex isn't a perfect reversal agent.
pubmed.ncbi.nlm.nih.gov/39443187/
Neuromuscular monitoring reduces the incidence of residual neuromuscular blockade after surgery. Sugammadex isn't a perfect reversal agent.
pubmed.ncbi.nlm.nih.gov/39443187/
Residual neuromuscular block in the postanaesthesia care unit: a single-centre prospective observational study and systematic review - PubMed
The incidence of residual neuromuscular block in the PACU was 2.2%. This suggests significant improvement in the prevention of residual neuromuscular block and stresses the importance of rigorous neur...
pubmed.ncbi.nlm.nih.gov
January 27, 2025 at 5:39 PM
Things we know that continue to be proven:
Neuromuscular monitoring reduces the incidence of residual neuromuscular blockade after surgery. Sugammadex isn't a perfect reversal agent.
pubmed.ncbi.nlm.nih.gov/39443187/
Neuromuscular monitoring reduces the incidence of residual neuromuscular blockade after surgery. Sugammadex isn't a perfect reversal agent.
pubmed.ncbi.nlm.nih.gov/39443187/
ACCP Critical Care PRN members, please complete the Spring recognition survey by February 17, 2025.
bit.ly/3WcL6JN
On behalf of the PRN recognition committee, we look forward to highlighting your success!
@vccpharmd.bsky.social
bit.ly/3WcL6JN
On behalf of the PRN recognition committee, we look forward to highlighting your success!
@vccpharmd.bsky.social
January 14, 2025 at 6:34 PM
ACCP Critical Care PRN members, please complete the Spring recognition survey by February 17, 2025.
bit.ly/3WcL6JN
On behalf of the PRN recognition committee, we look forward to highlighting your success!
@vccpharmd.bsky.social
bit.ly/3WcL6JN
On behalf of the PRN recognition committee, we look forward to highlighting your success!
@vccpharmd.bsky.social